Abilify - Market Research and Reports
Abilify (Aripiprazole) is an atypical antipsychotic produced by Bristol-Myers Squibb Company, with annual sales of $3m, ranking it 6th in the world for annual sales.
Abilify is prescribed in addition to other anti-depressants for the treatment of depression, and additionally for bipolar disorder and schizophrenia. The FDA has recently licensed it for use in treating irritability associated with Autistic Disorder in pediatric patients (ages 6 to 17), as part of a total treatment plan.
Source; Adapted from Bioportfolio.com and Abilify.com
BioPortfolio's Easy Ordering System
- Search for the report you need from our store
- Make online payment with our easy checkout process
- Receive PDF report via email
Easy Online Payment or Pro Forma Invoice
We accept the following credit cards...
or can supply a pro-forma invoice if required.